Myeloid cell interactions in atherosclerosis
Myeloid cell interactions in atherosclerosis
批准号:
9311933
负责人:
Klaus F. Ley
金额:
$45.0万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2021-04-30
关键词:
AddressAntigen PresentationAortaApolipoprotein EAreaArterial Fatty StreakArteriesAtherosclerosisBehaviorBiological ModelsBromodeoxyuridineCell CommunicationCell ShapeCellsCessation of lifeCharacteristicsColorDancingDataDendritesEndothelial CellsEndotheliumExternal carotid artery structureFundingGene ExpressionGene Expression ProfileGenesGeneticHot SpotITGAM geneImageIn SituInflammationInjectableIntegrin alpha4beta1IntegrinsLabelLeukocytesLigandsMeasuresMethodsMicroscopyMinimally modified Low Density LipoproteinModernizationMolecularMolecular ProfilingMonoclonal AntibodiesMovementMusMutationMyeloid CellsMyocardial InfarctionNaturePatternPeripheral arterial diseasePhenotypePrimary PreventionProliferatingResearchSecondary PreventionSpottingsStrokeSurfaceTechnologyTestingTimeWorkbasecadherin 5cell typechemokinechemokine receptordeep sequencingdifferential expressionexperimental studygenome-wideimage processingimaging systemin vivointravital microscopylive cell imagingmacrophagemicroscopic imagingmigrationmonocytemovieoxidized low density lipoproteinprogramstooltranscriptometranscriptome sequencinguptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Description
Although tremendous progress has been made in primary and secondary prevention, the complications of
atherosclerosis (heart attacks, strokes and peripheral artery disease) still account for the most deaths
worldwide. Here, we propose to test three hypotheses. This work has become possible through the intravital
live cell triggered imaging system (ILTIS) we developed in the current funding cycle. Hypothesis 1 is that non-
classical monocytes use LFA-1 (αLβ2 integrin) and ~40% also VLA-4 (α4β1 integrin) to patrol the endothelium
overlying atherosclerotic plaque. We have preliminary evidence for at least two subsets of patrolling monocytes
in atherosclerotic arteries. To test the molecular mechanism of patrolling, we will block integrins, their ligands,
chemokines and chemokine receptors using monoclonal antibodies. Hypothesis 2 is that blood monocytes gain
access to atherosclerotic plaque through the luminal endothelium. To test how monocytes enter atherosclerotic
lesions, we have made mice with yellow (YFP) endothelium that are crossed into the Apoe-/- atherosclerosis-
prone background. Combining these mice with mice in which monocyte subsets are fluorescently labeled
(Cx3cr1GFP/+ for non-classical, Ccr2RFP/+ for classical monocytes) will show transendothelial migration of
monocytes into atherosclerotic plaque in vivo. Hypothesis 3 is that four newly discovered plaque macrophage
subsets (by ILTIS) have different functions. Preliminary RNA-Seq data show that their gene expression profiles
vary significantly. We will test these functions: proliferation by BrdU and Ki67; oxLDL and minimally modified
(mm)LDL uptake; efferocytosis; migration and antigen presentation. When the proposed work is complete, we
will know, for the first time, how monocytes patrol atherosclerotic arteries, how they enter atherosclerotic
lesions and what they do there. We will identify key functions of the four newly discovered monocyte and
macrophage subsets in atherosclerotic plaque.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of kindlin-3-dependent integrin activation
-
批准号:10676897
-
项目类别:
-
资助金额:$54.92万
-
财政年份:2020
-
负责人:Klaus F. Ley
-
依托单位:
Mechanism of kindlin-3-dependent integrin activation
-
批准号:10229369
-
项目类别:
-
资助金额:$54.93万
-
财政年份:2020
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10112954
-
项目类别:
-
资助金额:$90.72万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10369710
-
项目类别:
-
资助金额:$58.9万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:9895858
-
项目类别:
-
资助金额:$90.7万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10623034
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10565907
-
项目类别:
-
资助金额:$76.97万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Core E: Cell sorting, CyTOF and RNA-Seq
-
批准号:10188604
-
项目类别:
-
资助金额:$54.45万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Core B: Single Cell Protein and RNA Sequencing Core
-
批准号:10334092
-
项目类别:
-
资助金额:$5.35万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Super-resolution confocal microscope
-
批准号:9274885
-
项目类别:
-
资助金额:$56.63万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
ApoB-specific CD4 T cells in mouse and human atherosclerosis
-
批准号:10188608
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Project 4: APOB-specific CD4 and CD8 T cells exacerbate atherosclerosis
-
批准号:10334097
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis
-
批准号:8819012
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2014
-
负责人:Klaus F. Ley
-
依托单位:
Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis
-
批准号:8966694
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2014
-
负责人:Klaus F. Ley
-
依托单位:
VASCULATA 2013: Vascular Immunology
-
批准号:8597858
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2013
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8675936
-
项目类别:
-
资助金额:$42.48万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8346057
-
项目类别:
-
资助金额:$56.61万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8499418
-
项目类别:
-
资助金额:$43.3万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:9065736
-
项目类别:
-
资助金额:$43.35万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Cell Phenotyping Core
-
批准号:8703257
-
项目类别:
-
资助金额:$10.93万
-
财政年份:2008
-
负责人:Klaus F. Ley
-
依托单位:
海外基金